Tandem Insulin Pumps
Tandem Diabetes Care is the #1 recommended insulin pump brand by people living with diabetes — four years and counting!2
COLOR TOUCHSCREEN
t:slim X2™ Insulin Pump
Sleek and modern, the t:slim X2 pump is easy to use with a color touchscreen and can pair with multiple CGM sensors. When used with Control-IQ technology, it is the #1 rated automated insulin delivery system.3
IMPRESSIVELY SMALL
Tandem Mobi System
This insulin pump can be worn almost anywhere, giving you more options for how you manage your diabetes. It’s powered by Control-IQ technology and is controllable by a compatible iPhone.†
Which Tandem system is right for you?
Compare Tandem Systems
AUTOMATIC ADJUSTMENTS
Control-IQ technology automatically adjusts insulin levels based on Dexcom continuous glucose monitoring (CGM) readings*.
CORRECTION BOLUSES
Control-IQ technology can also deliver automatic correction boluses (up to one an hour) to help prevent hyperglycemia.
ACTIVITY SETTINGS
Control-IQ technology includes optional settings for sleep and exercise activities that adjust treatment ranges for more control.
Zero Fingersticks
Tandem integrates with Dexcom continuous glucose monitoring systems to provide exceptional accuracy for optimized insulin delivery.2 Dexcom is the first real-time, integrated continuous glucose monitoring (iCGM) system requiring zero fingersticks for calibration or mealtime dosing.*
Please note: The t:slim X2 pump integrates with both Dexcom G6 and Dexcom G7, but at launch (March 2024), the Tandem Mobi system only works with Dexcom G6.
Ready to Get Started?
Apply Today
t:connect Mobile App**
Use your smart phone with the t:connect mobile app as a secondary display for your t:slim X2 insulin pump.
-
View messages and alerts from your insulin pump as push notifications on your phone
-
Easily view your pump data, including basal and bolus events, right on your phone
———- FREQUENTLY ASKED QUESTIONS ———-
Control‑IQ technology is designed to help increase time in range using your Dexcom G6 or G7 CGM values to predict glucose levels 30 minutes ahead and adjust insulin delivery accordingly. Icons on the pump screen indicate when insulin dosing is increasing, decreasing, or being stopped by the system.
The Tandem Mobi system is water-resistant (IP28) and has been tested at 8 feet for 2 hours. The t:slim X2 is watertight (IP27) and has been tested to 3 feet for 30 minutes.
The t:slim X2 insulin pump is up to 38% smaller than other insulin pumps, yet still holds up to 300 units of insulin.
The Mobi system is half the size of a t:slim X2 pump and holds 200 units of insulin.
The Tandem Mobi is compatible with all Tandem infusion sets, including a new 5-inch tubing option for the AutoSoft XC that was designed specifically for on-body wear with the Tandem Mobi system. (An optional adhesive sleeve is recommended for on-body wear.)
Yes, Medicare covers Tandem insulin pump therapy for eligible beneficiaries. The t:slim X2 is already available. The Tandem Mobi has been approved by Medicare, but is not yet to market.
Bolus delivery to your Tandem insulin pump from the t:connect mobile app requires a compatible smartphone model and operating system. The t:slim X2 works with a variety of iOS and Android devices. At product launch in March 2024, the Tandem Mobi system only works with certain versions of iPhone devices.
Refer to Tandem’s website for more information on device compatibility: https://www.tandemdiabetes.com/products/software-apps/device-compatibility
Technology evolves at a rapid pace, which is why Tandem pumps feature remote software updates for pumps that get updated, not outdated! Remote software updates during the warranty period make it easy and affordable for users to have the most up-to-date software and latest features to improve diabetes management.
Please note: Future updates for all or some Tandem products may not be developed and may not be offered everywhere and would be subject to applicable regulatory approvals. Software updates are only available to customers who are in-warranty at the time they update their pump. Additional training may be required to access certain software updates. Charges may apply. Tandem may discontinue select software and features over time at its discretion.
EHCS is an authorized distributor of Tandem Insulin Pumps. We strive to provide you with quality products and multiple options.
2. dQ&A US Diabetes Connections Patient Panel Report; Net Promoter Score; Jan. 2019-Sept. 2023: P.49, Sept. 2023
3. dQ&A US Patient Panel Q3 2023 (July-Sept. 2023).
† The mobile app requires a compatible iPhone model and operating system (sold separately): https://support.tandemdiabetes.com/hc/en-us/articles/360039080154-Mobile-App-Compatibility
* Dexcom CGM sold separately. Check with Tandem to ensure your pump software is compatible with your Dexcom CGM system.
Important Safety Information: RX ONLY.
Indications for Use
Tandem Mobi system: The Tandem Mobi insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is intended for single patient, home use and requires a prescription. The pump is indicated for use in individuals 6 years of age and greater.
t:slim X2 insulin pump: The t:slim X2 insulin pump with interoperable technology is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is intended for single patient use. The pump is indicated for use with NovoLog or Humalog U-100 insulin. The pump is indicated for use in individuals 6 years of age and greater.
Control-IQ technology: Control-IQ technology is intended for use with compatible integrated continuous glucose monitors (iCGM, sold separately) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ technology is intended for the management of Type 1 diabetes mellitus in persons 6 years of age and greater. Control-IQ technology is intended for single patient use. Control-IQ technology is indicated for use with NovoLog or Humalog U-100 insulin.
Warning: Control-IQ technology should not be used by anyone under the age of 6 years old. It should also not be used in patients who require less than 10 units of insulin per day or who weigh less than 55 pounds.
**The information on the t:connect mobile app display may not be identical to the current status of your pump. Wireless uploads from the t:connect mobile app to the cloud-based t:connect web application require a compatible phone and an internet or wireless data connection. Uploads to the t:connect web application do not take place in real time and should not be relied upon by healthcare providers or caregivers for remote patient monitoring. Standard carrier data rates may apply.